Jazz Pharma Stock Price (NASDAQ:JAZZ)

Add to My Stocks
$160.98 $0.15 (0.09%) JAZZ stock closing price Jul 24, 2017 (Closing)
Prev Close* : $161.13
Market Cap:
$9.68B
Day Low: $158.92
52 Week Low: $95.80
Open: $161.8
Volume: 413279
Day High: $162.41
52 Week High: $163.75
Dividend:
N/A

Latest Stock Market News

Latest Articles

Jazz Pharma News - From Partners

JAZZ Stockcharts

View JAZZ PE ratio, PS ratio stocks charts and compare with peers.
JAZZ Chart
Note: Compare Jazz Pharma stock price history with the index and industry peers.

Jazz Pharma Valuation

PE ratio
(price earnings ratio)
24.65
PS ratio (
price to sales ratio
)
6.31
PB ratio (
price to book ratio
)
5.43

Jazz Pharma Returns

ROE
(return on equity)
23%

Jazz Pharma Financial Ratios

Asset Turnover
0.31
Receivables Turnover
6.53
Debt to Equity
0.95

JAZZ Industry Peers

Company Price Change (%)
Salix Pharma (SLXP)172.810 (0%)
Ipsen Sa Adr (IPSEY)32.810 (0%)
Teva Pharmaceutical (TEVA)32.470.17 (0.52%)
Valeant Pharmaceuticals Intl Inc (VRX)17.540.04 (0.23%)
Roche Holdings (RHHBY)32.150.12 (0.37%)
Express Scripts Holding (ESRX)62.610.11 (0.18%)
Concert Pharma (CNCE)16.12.07 (14.75%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
AcelRx Pharma (ACRX)3.650.5 (15.87%)
Genocea Biosciences (GNCA)5.830.78 (15.45%)
Concert Pharma (CNCE)16.12.07 (14.75%)
ImmunoGen (IMGN)6.340.68 (12.01%)
GlycoMimetics (GLYC)12.10.6 (5.22%)
Arrowhead Pharma (ARWR)1.580.07 (4.64%)
Catalyst Pharma (CPRX)3.080.13 (4.41%)
Top gainers from Medical-Drugs industry
* As of Jul 24, 2017
CompanyPriceChange (%)
Tetraphase Pharmaceuticals (TTPH)7.30.79 (9.77%)
Endo International (ENDP)11.670.71 (5.74%)
BioCryst Pharma (BCRX)5.20.21 (3.88%)
Corcept Therapeutics (CORT)12.530.44 (3.39%)
Lannett Co (LCI)210.5 (2.33%)
Durect (DRRX)1.840.03 (1.6%)
Grifols (GRFS)20.370.33 (1.59%)
Top losers from Medical-Drugs industry
* As of Jul 24, 2017

Jazz Pharmaceuticals plc - Ordinary Shares Stock News - Partner Headlines

  on May 12, 2017

Jazz Pharma Financial Statements

income statement20162015201420132012
Net Sales Or Revenues1.49B1.32B1.17B872.42M585.97M
Net Income396.83M329.53M58.38M216.31M288.58M
Total Operating Expense790.92M714.05M859.85M429.96M309.7M
view Jazz Pharmaceuticals plc - Ordinary Shares income statement
balance sheet20162015201420132012
Total Assets4.8B3.36B3.34B2.24B1.97B
Total Liabilities2.92B1.76B1.97B942.68M845.2M
Shareholders Equity1.88B1.6B1.37B1.3B1.12B
view Jazz Pharmaceuticals plc - Ordinary Shares balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities-22.71M-6.11M-66.34M-80.95M-5.15M
Net Cash From (Used By) Operating Activities590.53M531.94M405.76M283.61M249.75M
Increase (Decrease) In Prop Plant And Equipment-7.83M-35.95M-36.34M-9.97M-5.97M
view Jazz Pharmaceuticals plc - Ordinary Shares cashflow statement

Jazz Pharma Stock Message Board

Jazz Pharma stock lost 0.8 %, and the last close price as of 21 Jul, 2017 is 161.13 for JAZZ stock. The total market value as denoted by 9.61B for Jazz Pharma, is the market value of the company's outstanding shares. Jazz Pharma valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

Demand for a stock decides its stock market price. For example, if more investors want to buy JAZZ stock than sell it, then Jazz Pharma stock price goes up. Conversely, if more investors wanted to sell JAZZ stock than buy it, there would be greater supply than demand, and the stock price would fall. 417151 JAZZ shares were traded yesterday, and Jazz Pharma stock chart shows that the JAZZ stock quote hit a day high of 161.65 and day low of 158.6. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. To check the historical stock price movement, all time high, and all time low of JAZZ, view Jazz Pharma stock price history.